Antibodies as Drug Carriers III: Design of Oligonucleotides with Enhanced Binding Affinity for Immunoglobulin G

Author： Palma Enzo   Klapper David G.   Cho M. J.  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.22, Iss.1, 2005-01, pp. : 122-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Design for Protein Kinases and Phosphatases: Flexible-Receptor Docking, Binding Affinity and Specificity, and Drug-Binding Kinetics

By  

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4739-4754

Bentham Science Publishers

Access to resources Recommend Favorite

Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

By Jing N.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

Peptide-Binding G Protein-Coupled Receptors: New Opportunities for Drug Design

By  

Current Medicinal Chemistry, Vol. 8, Iss. 13, 2001-11 ,pp. : 1605-1648

Bentham Science Publishers

Access to resources Recommend Favorite

Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid

By Bergquist J.   Traskman-Bendz L.   Lindstrom M.B.   Ekman R.  

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite